India's First MRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical Tr

[email protected]14 Oct, 2021News

India's first indigenous mRNA Covid-19 vaccine candidate, which is being developed by Pune-based Gennova Biopharmaceuticals Limited, has been found safe, tolerable, and immunogenic in the participants of the phase-1 study. Gennova Biopharmaceuticals had submitted the interim clinical data of the Phase I study of the vaccine to the Central Drugs Standard Control Organisation (CDSCO), which is the Indian drug regulatory authority.

Recent Profiles

Integrity Restrooms

Integrity Restrooms

View Profile

Ramatech Machine Tools

Ramatech Machine Tools

View Profile

Rcrisp Solutions India Pvt. Ltd.

Rcrisp Solutions India Pvt. Ltd.

View Profile

Aspire Holidays

Aspire Holidays

View Profile

Futk Olik

Futk Olik

View Profile

Business Manager

Business Manager

View Profile

888P – Trang chủ nhà cái uy tín 888p uk com

888p – Trang Chủ Nhà Cái Uy Tín 888p Uk Com

View Profile

Chiku Cab

Chiku Cab

View Profile

JK Plumbing

Jk Plumbing

View Profile